Pham, Edward A.
Perumpail, Ryan B.
Fram, Benjamin J.
Glenn, Jeffrey S.
Ahmed, Aijaz
Gish, Robert G.
Funding for this research was provided by:
National Institutes of Health (RO1 AI099245)
National Institutes of Health (U19 AI109662)
Howard Hughes Medical Institute (F30DK099017)
Article History
First Online: 10 November 2016
Compliance with Ethical Standards
:
: Edward A. Pham, Dr. Ryan B. Perumpail, Benjamin J. Fram, Dr. Jeffrey S. Glenn, and Dr. Aijaz Ahmed report that they have no conflicts of interest.Dr. Robert G. Gish reports grants/research support from Gilead, Merck, Benitec, AbbVie; consultancy/advising for Abbott, AbbVie, Akshaya, Alexion, Arrowhead, Astra-Zeneca, Bayer AG, Bristol-Myers Squibb Company, Contravir, Eiger, Enyo, Genentech, Gilead Sciences, Hoffmann-LaRoche Ltd., Humabs, Intellia, Intercept, Ionis Pharmaceuticals, Isis, Janssen, MedImmune, MERCK, Nanogen, Novira; and Quest; speaker’s contracts with Alexion, Bayer, BMS, Gilead Sciences Inc., Salix/Valeant, AbbVie, and Merck; and stock in Kinex, Synageva, RiboSciences, CoCrystal, and Arrowhead; outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.